Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF584 divergent transcript (ZNF584-DT) is a long non-coding RNA (lncRNA) located near the ZNF584 gene on the human genome. Its name indicates it is transcribed divergently from the ZNF584 locus. ZNF584-DT is cataloged in several genomic resources as a distinct non-coding transcript; however, there is currently no specific evidence linking it to a biological function, disease association, or therapeutic targeting. Like many other divergent transcripts, ZNF584-DT may result from promoter architecture that produces non-coding RNAs through processes of divergent transcription. No drugs, clinical biomarkers, or safety considerations are known or reported for this transcript. Sources consulted directly confirm ZNF584-DT as a genomic entity but do not support its classification as a therapeutic target or provide functional annotation beyond its genomic identity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF584 divergent transcript (ZNF584-DT).